本文選題：奧曲肽 + 大黃屬��； 參考：《重慶醫(yī)學》2015年24期

【摘要】：目的系統(tǒng)評價大黃與奧曲肽聯(lián)用治療急性胰腺炎的有效性和安全性。方法計算機檢索中國生物醫(yī)學文獻數(shù)據(jù)庫(CBM)、維普(VIP)、中國知網(wǎng)(CNKI)、PubMed和萬方數(shù)據(jù)庫,查找有關應用奧曲肽與大黃聯(lián)用治療急性胰腺炎的隨機對照試驗(RCT),并追索納入文獻的參考文獻,檢索時限:2008年1月至2014年12月。英文檢索詞為"Octreotide","rhubarb","ASP",中文檢索詞為"大黃"、"奧曲肽"、"急性胰腺炎"。2位評價員按照Corchrane系統(tǒng)評價方法,預先制定納入標準和排除標準,對檢索的文獻進行獨立篩選、數(shù)據(jù)提取和文獻評估,交叉核對相關數(shù)據(jù),使用RevMan 5.2軟件分析。結果納入10篇RCT,共655例受試者(試驗組336例,對照組319例)。Meta分析結果顯示:與單用奧曲肽相比,大黃聯(lián)合奧曲肽可以提高顯效率[RR=1.47,95%CI(1.21,1.78),P0.01]和總有效率[RR=1.19,95%CI(1.09,1.29),P0.01];試驗組與對照組在縮短腹痛時間、血淀粉酶恢復時間、排便恢復時間、患者住院時間、腹脹消失時間、嘔吐消失時間、尿淀粉酶恢復時間、腹壓痛消失時間方面,均差異有統(tǒng)計學意義(P0.01);可降低轉手術率,但差異無統(tǒng)計學意義(P0.05);兩組安全性方面未見嚴重不良反應報道。結論與單用奧曲肽相比,奧曲肽聯(lián)合大黃治療急性重癥胰腺炎能提高奧曲肽的臨床療效,安全性較好。
[Abstract]:Objective to evaluate the efficacy and safety of combined use of rhubarb and octreotide in the treatment of acute pancreatitis. Methods computer retrieval of Chinese biomedical literature database (CBM), VIP, CNKI, PubMed and Wanfang database were used to find a randomized controlled trial (RCT) for the treatment of acute pancreatitis with octreotide and rhubarb (RCT). Recourse to the reference literature, retrieval time limit: January 2008 to December 2014. English retrieval words "Octreotide", "rhubarb", "ASP", Chinese retrieval words "rhubarb", "octreotide", "acute pancreatitis".2 evaluators in accordance with the Corchrane system evaluation method, pre formulation of the inclusion criteria and exclusion criteria, independent screening of the literature for screening. Selection, data extraction and literature evaluation, cross checking related data, using RevMan 5.2 software analysis. The results were included in 10 RCT. A total of 655 subjects (336 cases in test group and 319 control group) showed.Meta analysis. Compared with octreotide, rhubarb combined octreotide could improve the efficiency of [RR=1.47,95%CI (1.21,1.78), P0.01] and total effective [RR =1.19,95%CI (1.09,1.29), P0.01], the test group and the control group had a significant difference in shortening the time of abdominal pain, the time of blood amylase recovery, the recovery time of defecation, the time of hospitalization, the time of disappearance of abdominal distention, the time of disappearance of vomit, the time of the recovery of urine amylase, and the disappearance time of abdominal pressure pain (P0.01), which could reduce the rate of operation, but the difference was no unification. No serious adverse reactions were reported in the two groups. Conclusion compared with octreotide alone, octreotide combined with rhubarb can improve the clinical efficacy of octreotide in the treatment of acute severe pancreatitis, and the safety is better.

【作者單位】： 瀘州醫(yī)學院附屬醫(yī)院人力資源部;瀘州醫(yī)學院附屬醫(yī)院藥學部;
【基金】：四川省衛(wèi)生廳資助(130369)
【分類號】：R576

【參考文獻】

相關期刊論文 前10條

1 伍煜倫;陳偉倫;趙青山;;奧曲肽聯(lián)合生大黃治療急性胰腺炎療效觀察[J];廣東醫(yī)學;2008年05期

2 連善華;上官潔;;奧曲肽聯(lián)合應用大黃對重癥胰腺炎的臨床療效觀察[J];海峽藥學;2011年02期

3 蔡以友;;奧曲肽聯(lián)合應用生大黃治療急性胰腺炎療效觀察[J];吉林醫(yī)學;2011年07期

4 陳濤;占強;郭繼中;;奧曲肽聯(lián)合早期應用生大黃治療重癥急性胰腺炎療效觀察[J];內(nèi)蒙古中醫(yī)藥;2009年24期

5 陳菊;;奧曲肽聯(lián)合中藥治療重癥急性胰腺炎的臨床研究[J];臨床合理用藥雜志;2010年10期

6 李加龍;;大黃胃管注入聯(lián)合奧曲肽治療急性胰腺炎隨機平行對照研究[J];實用中醫(yī)內(nèi)科雜志;2013年17期

7 ;中國急性胰腺炎診治指南(草案)[J];中國消化內(nèi)鏡;2007年10期

8 黎卓江;;奧曲肽聯(lián)合生大黃治療急性胰腺炎的療效觀察[J];醫(yī)學信息(中旬刊);2011年09期

9 姜良富;;大黃對重癥急性胰腺炎的影響及細菌移位研究[J];中國醫(yī)藥導報;2010年03期

10 黃付春;丁紅玲;;奧曲肽聯(lián)合生大黃用于治療急性胰腺炎的療效觀察[J];中國社區(qū)醫(yī)師(醫(yī)學專業(yè));2012年05期

【共引文獻】

相關期刊論文 前10條

1 但震宇;梁久銀;龔仁華;李凱瑯;李勇;王濤;李靖;;自擬清胰湯聯(lián)合皮硝對急性胰腺炎合并胰周液體積聚的治療作用[J];中醫(yī)藥臨床雜志;2009年04期

2 章敢;;重癥急性胰腺炎33例臨床分析[J];安徽衛(wèi)生職業(yè)技術學院學報;2006年03期

3 劉雷;胡志萬;方茂勇;;急性膽源性胰腺炎膽道手術干預療效的臨床分析[J];安徽衛(wèi)生職業(yè)技術學院學報;2011年05期

4 開U，

本文編號：1871914